# Exelon Corp: overview

EXC · Nasdaq · CIK 1109357 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/exc.md) · [Financials](/companies/exc/financials.md) · [Filings](/companies/exc/filings.md) · [Insiders](/companies/exc/insiders.md)

Latest reported revenue: [$7.24bn](/filings/0001109357-26-000063.md) for Q1 FY2026, three months to 2026-03-31, from the 10-Q filed May 6, 2026 (XBRL us-gaap:Revenues, accession 0001109357-26-000063).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,361](/filings/0001109357-25-000170.md) | [6,154](/filings/0001109357-25-000182.md) | [5,471 d](/filings/0001109357-26-000018.md) | [6,714](/filings/0001109357-26-000063.md) | [5,427](/filings/0001109357-25-000170.md) | [6,705](/filings/0001109357-25-000182.md) | [5,412 d](/filings/0001109357-26-000018.md) | [7,242](/filings/0001109357-26-000063.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [17.0%](/filings/0001109357-25-000170.md) | [19.4%](/filings/0001109357-25-000182.md) | [20.1% d](/filings/0001109357-26-000018.md) | [22.9%](/filings/0001109357-26-000063.md) | [17.1%](/filings/0001109357-25-000170.md) | [22.4%](/filings/0001109357-25-000182.md) | [21.9% d](/filings/0001109357-26-000018.md) | [22.2%](/filings/0001109357-26-000063.md) |
| Net margin | % | [8.4%](/filings/0001109357-25-000182.md) | [11.5%](/filings/0001109357-25-000182.md) | [11.8% d](/filings/0001109357-26-000018.md) | [13.5%](/filings/0001109357-26-000063.md) | [7.2%](/filings/0001109357-25-000182.md) | [13.0%](/filings/0001109357-25-000182.md) | [11.0% d](/filings/0001109357-26-000018.md) | [12.7%](/filings/0001109357-26-000063.md) |
| Diluted EPS | $ per share | [0.45](/filings/0001109357-25-000170.md) | [0.70](/filings/0001109357-25-000182.md) | not reported | [0.90](/filings/0001109357-26-000063.md) | [0.39](/filings/0001109357-25-000170.md) | [0.86](/filings/0001109357-25-000182.md) | not reported | [0.90](/filings/0001109357-26-000063.md) |
| Free cash flow | $m | [(237) d](/filings/0001109357-25-000170.md) | [(6.0) d](/filings/0001109357-25-000182.md) | [(510) d](/filings/0001109357-26-000018.md) | [(746)](/filings/0001109357-26-000063.md) | [(502) d](/filings/0001109357-25-000170.md) | [163 d](/filings/0001109357-25-000182.md) | [(1,190) d](/filings/0001109357-26-000018.md) | [(634)](/filings/0001109357-26-000063.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [17.9](/filings/0001109357-24-000053.md) | [19.1](/filings/0001109357-25-000043.md) | [21.7](/filings/0001109357-26-000018.md) | [23.0](/filings/0001109357-26-000018.md) | [24.3](/filings/0001109357-26-000018.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [15.0%](/filings/0001109357-24-000053.md) | [17.4%](/filings/0001109357-25-000043.md) | [18.5%](/filings/0001109357-26-000018.md) | [18.8%](/filings/0001109357-26-000018.md) | [21.2%](/filings/0001109357-26-000018.md) |
| Net margin | % | [10.2%](/filings/0001109357-24-000053.md) | [11.4%](/filings/0001109357-25-000043.md) | [10.7%](/filings/0001109357-26-000018.md) | [10.7%](/filings/0001109357-26-000018.md) | [11.4%](/filings/0001109357-26-000018.md) |
| Diluted EPS | $ per share | [1.74](/filings/0001109357-22-000039.md) | not reported | not reported | not reported | not reported |
| Free cash flow | $bn | [(5.0)](/filings/0001109357-24-000053.md) | [(2.3)](/filings/0001109357-25-000043.md) | [(2.7)](/filings/0001109357-26-000018.md) | [(1.5)](/filings/0001109357-26-000018.md) | [(2.3)](/filings/0001109357-26-000018.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/exc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $5.58bn | 119,770,685 |  | Added +7,021,076 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.15bn | 67,464,176 |  | Reduced −107,789 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.11bn | 66,799,154 |  | Added +783,466 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.62bn | 56,233,966 |  | Added +1,568,532 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $2.39bn | 51,262,524 |  | Added +11,187,932 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $1.78bn | 38,112,879 |  | Added +22,146,127 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.50bn | 32,376,504 |  | Added +650,765 |
| [LAZARD ASSET MANAGEMENT LLC](/funds/1207017.md) | 2026-06-30 | $1.50bn | 32,169,502 |  | Added +7,549,198 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $939.2m | 20,145,585 |  | Reduced −283,580 |
| [GQG Partners LLC](/funds/1697233.md) | 2026-06-30 | $922.9m | 19,796,580 |  | Reduced −2,481,621 |

## Recent filings

[All 3,065 filings](/companies/exc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 06:57 ET | [8-K](/filings/0001109357-26-000092.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001109357-26-000092 |
| 2026-08-25 | 16:38 ET | [8-K](/filings/0001109357-26-000084.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001109357-26-000084 |
| 2026-07-30 | 13:24 ET | [10-Q](/filings/0001109357-26-000080.md) | Quarterly report, period 2026-06-30 | 0001109357-26-000080 |
| 2026-07-30 | 06:56 ET | [8-K](/filings/0001109357-26-000077.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001109357-26-000077 |
| 2026-05-06 | 14:18 ET | [10-Q](/filings/0001109357-26-000063.md) | Quarterly report, period 2026-03-31 | 0001109357-26-000063 |
| 2026-05-06 | 06:56 ET | [8-K](/filings/0001109357-26-000061.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001109357-26-000061 |
| 2026-04-30 | 16:28 ET | [8-K](/filings/0001109357-26-000053.md) | 5.07 Shareholder vote results | 0001109357-26-000053 |
| 2026-04-16 | 12:06 ET | [8-K](/filings/0001109357-26-000046.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001109357-26-000046 |
| 2026-03-18 | 14:10 ET | [DEF 14A](/filings/0001109357-26-000040.md) | Proxy statement, period 2026-04-28 | 0001109357-26-000040 |
| 2026-02-20 | 14:23 ET | [8-K](/filings/0001109357-26-000021.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001109357-26-000021 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001109357-26-000018.md), filed Feb 12, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1109357
- Tickers: EXC
- Exchange: Nasdaq
- SIC code: 4931 Electric & Other Services Combined
- State of incorporation: PA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 12:46 ET. No prices; not investment advice.